Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,928 | 712 | 96.2% |
| Education | $457.35 | 15 | 3.4% |
| Gift | $53.70 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,744 | 94 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,637 | 96 | $0 (2024) |
| Astellas Pharma US Inc | $1,091 | 42 | $0 (2024) |
| ABBVIE INC. | $878.47 | 51 | $0 (2024) |
| Lilly USA, LLC | $851.38 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $772.86 | 42 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $674.41 | 33 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $589.25 | 48 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $480.69 | 24 | $0 (2023) |
| PFIZER INC. | $423.70 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,412 | 62 | AstraZeneca Pharmaceuticals LP ($297.26) |
| 2023 | $1,801 | 82 | Bayer Healthcare Pharmaceuticals Inc. ($211.64) |
| 2022 | $1,658 | 86 | Novo Nordisk Inc ($264.93) |
| 2021 | $2,109 | 111 | AbbVie Inc. ($470.38) |
| 2020 | $1,810 | 110 | AstraZeneca Pharmaceuticals LP ($245.88) |
| 2019 | $1,594 | 95 | Novo Nordisk Inc ($302.05) |
| 2018 | $1,580 | 92 | AstraZeneca Pharmaceuticals LP ($240.18) |
| 2017 | $1,476 | 90 | Astellas Pharma US Inc ($201.84) |
All Payment Transactions
728 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Biological | ||||||
| 10/18/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Obesity | ||||||
| 10/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Biological | ||||||
| 10/01/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.46 | General |
| Category: GI | ||||||
| 08/14/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: Insulin Pump | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Respiratory | ||||||
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Diabetes Care | ||||||
| 06/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $29.75 | General |
| Category: GI | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), AIRSUPRA | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 720 | 1,156 | $154,404 | $66,448 |
| 2022 | 14 | 1,054 | 1,453 | $192,220 | $87,332 |
| 2021 | 14 | 1,128 | 1,671 | $256,146 | $122,941 |
| 2020 | 15 | 707 | 1,088 | $177,138 | $74,570 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 255 | 614 | $87,802 | $38,797 | 44.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 103 | 103 | $22,042 | $8,107 | 36.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 49 | 69 | $17,250 | $7,159 | 41.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 56 | 58 | $5,220 | $2,008 | 38.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 42 | 48 | $3,820 | $1,946 | 51.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,575 | $1,677 | 46.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 33 | $3,036 | $1,668 | 55.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $1,620 | $1,295 | 79.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 16 | $3,328 | $1,222 | 36.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 30 | 62 | $1,984 | $981.80 | 49.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,375 | $812.50 | 59.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 23 | 24 | $1,032 | $388.80 | 37.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $1,440 | $197.71 | 13.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 44 | 55 | $880.00 | $187.55 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 225 | 441 | $63,063 | $27,159 | 43.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 183 | 263 | $24,196 | $14,952 | 61.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 146 | 146 | $22,192 | $10,771 | 48.5% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 57 | 83 | $20,750 | $8,546 | 41.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 99 | 99 | $21,186 | $8,178 | 38.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 148 | 179 | $16,110 | $6,243 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $10,725 | $5,176 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 34 | $7,072 | $3,195 | 45.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 14 | 14 | $1,260 | $956.28 | 75.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 27 | 56 | $1,792 | $884.54 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 20 | $1,100 | $640.70 | 58.2% |
About Dr. Gilberto Ramirez, MD
Dr. Gilberto Ramirez, MD is a Family Medicine healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518981448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilberto Ramirez, MD has received a total of $13,439 in payments from pharmaceutical and medical device companies, with $1,412 received in 2024. These payments were reported across 728 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($12,928).
As a Medicare-enrolled provider, Ramirez has provided services to 3,609 Medicare beneficiaries, totaling 5,368 services with total Medicare billing of $351,291. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Internal Medicine
- Location Bloomfield, CT
- Active Since 07/26/2006
- Last Updated 12/14/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1518981448
Products in Payments
- Ozempic (Drug) $1,134
- ENTRESTO (Drug) $728.93
- BREZTRI (Drug) $603.00
- UBRELVY (Drug) $543.67
- FARXIGA (Drug) $441.41
- XIFAXAN (Drug) $385.07
- MYRBETRIQ (Drug) $356.77
- XARELTO (Drug) $349.94
- VRAYLAR (Drug) $340.06
- SYMBICORT (Drug) $334.11
- Kerendia (Drug) $324.10
- Linzess (Drug) $314.30
- MOUNJARO (Drug) $297.87
- JARDIANCE (Drug) $269.19
- Rybelsus (Drug) $260.35
- INVOKANA (Drug) $233.29
- Myrbetriq (Drug) $206.99
- STIOLTO RESPIMAT (Drug) $190.20
- AJOVY (Biological) $189.97
- TRULICITY (Drug) $184.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bloomfield
Dr. Rochelle Collins, Do, DO
Family Medicine — Payments: $5,318
Mrs. Hemlata Bhatia, Md, MD
Family Medicine — Payments: $4,980
Kennett Asher, D. O, D. O
Family Medicine — Payments: $4,833
Yasmen Srour, M.d, M.D
Family Medicine — Payments: $2,886
Christine Hanna, Md, MD
Family Medicine — Payments: $2,115
Dr. Donald Wirtanen, D.o, D.O
Family Medicine — Payments: $1,388